Back
Speaker illustration

undefined undefined undefined

Presentations

Cardiac resynchronization therapy in patients with a history of atrial fibrillation: insights from five major clinical trials

Event: EHRA 2022

Topic: Device Treatment

Session: CRT news

Access
Like
Thumbnail

Rate versus rhythm control and mortality in atrial fibrillation patients: a danish nationwide cohort study

Event: ESC Congress 2019

Topic: Treatment

Session: Blockbusters from the Young in atrial fibrillation and cardiac resynchronisation therapy

Access
Like
Thumbnail

Increased risk of cardiovascular events and stroke among patients with atrial fibrillation and obstructive sleep apnea

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Epidemiology of atrial fibrillation, miscellaneous

Access
Like
Thumbnail

Rate lowering and anti-arrhythmic drugs as monotherapy or dual therapy on the risk of pacemaker implantation in patients with atrial fibrillation

Event: EHRA 2018

Topic: Antiarrhythmic Drug Treatment

Session: Young EP Poster Session - Young meets Experienced

Access
Like
Thumbnail

Risk factors of permanent pacemaker implantation in patients with new onset atrial fibrillation

Event: ESC Congress 2017

Topic: Risk scores

Session: Adverse outcome in patients with cardiometabolic disorders

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources